Solan Headlines

The Global Sepsis Diagnostics Market Evaluated to Advance at $900.7 Million by 2028

 Breaking News
  • No posts were found

The Global Sepsis Diagnostics Market Evaluated to Advance at $900.7 Million by 2028

June 16
15:02 2021
The Global Sepsis Diagnostics Market Evaluated to Advance at $900.7 Million by 2028

The Global Sepsis Diagnostics Market
As per Triton’s research report, in 2020, the global sepsis diagnostics market gained $605.0 million, and is predicted to progress at a CAGR of 8.18% by 2028.

A recent study by Triton Market Research titled ‘Global Sepsis Diagnostics Market’ entails the Global Analysis and Forecasts by Product (Assay Kits & Reagents, Instruments, Blood Culture Media), Pathogen (Gram-Positive and Gram-Negative Bacterial Sepsis, Fungal Sepsis, Other Pathogens), Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), Testing Type (Laboratory Testing, Point-of-Care Testing), Diagnostic Method (Conventional Diagnostics, Automated Diagnostics), and by Geography (Latin America, Middle East and Africa, North America, Europe, Asia-Pacific). 

Sepsis is a severe condition that arises from the body’s response to pathogenic organisms in the blood. The technologies used to diagnose sepsis includes molecular diagnostics, immunoassay, and microbiology, among other technologies.

 

Request Free Sample of the Global Sepsis Diagnostics Market Report @ https://www.tritonmarketresearch.com/reports/sepsis-diagnostics-market#request-free-sample

 

Triton’s research report estimates the global sepsis diagnostics market to grow at a CAGR of 8.18% during the years 2021-2028, garnering revenue worth $900.7 million by 2028.

Hospital-acquired infections are deemed to be among the most common complications among patients, resulting in a large number of deaths each year. Some of the most prevalent HAIs include surgical infection, respiratory infection, and bloodstream infection. This increase in HAIs boosts the need for sepsis diagnosis. Hence, the increasing cases of hospital-acquired infections are stimulating the expansion of the sepsis diagnostics market globally.

However, the elevated cost of diagnostics instruments and reimbursement issues are hampering the growth of the sepsis diagnostics market on a large scale.

The sepsis diagnostics market is broadly segmented into product, pathogen, technology, testing type, and diagnostic method. Based on product, it is sectioned into assay kits & reagents, instruments, and blood culture media. In terms of pathogen, it is sectioned into gram-positive and gram-negative bacterial sepsis, fungal sepsis, and other pathogens. The technology segment is branched into immunoassay, molecular diagnostics, microbiology, and other technologies. Further, testing type is divided into laboratory testing and point-of-care testing. Lastly, the diagnostic method is subdivided into conventional diagnostics and automated diagnostics. 

Globally, North America is dominating the sepsis diagnostics market. The advancement healthcare industry is one of the major factors responsible for the growth of the reviewed market in the region. Additionally, the high mortality rate associated with sepsis patients is augmenting the demand for sepsis diagnostics in the US and Canada. Besides, the favorable healthcare reimbursement policies initiated by the governments are increasing the adoption of automated sepsis diagnostic analyzers. Hence, as stated above, all these factors play a major role in driving the sepsis diagnostics market on a growth path in the US and Canada.

EKF Diagnostics, Thermo Fisher Scientific Inc, Becton Dickinson and Company (CR Bard), Bruker Corporation, Response Biomedical Corporation, Luminex Corporation, Immunexpress Inc, Abbott Laboratories, Cytosorbents, Biomerieux SA, T2 Biosystems Inc, Danaher Corporation, and F Hoffmann-La Roche are well-known companies in the sepsis diagnostics market.

 

Purchase this Report @ https://www.tritonmarketresearch.com/reports/sepsis-diagnostics-market#purchase-option

 

 

Question & Answer: Sepsis Diagnostics Market

Question 1: What major factor is stimulating the expansion of the sepsis diagnostics market globally?

Answer: Hospital-acquired infections are deemed to be among the most common complications among patients, resulting in a large number of deaths each year. Some of the most prevalent HAIs include surgical infection, respiratory infection, and bloodstream infection. This increase in HAIs boosts the need for sepsis diagnosis. Hence, the increasing cases of hospital-acquired infections are stimulating the expansion of the sepsis diagnostics market globally.

Question 2: What factors are hampering the growth of the sepsis diagnostics market?

Answer: The elevated cost of diagnostics instruments and reimbursement issues are hampering the growth of the sepsis diagnostics market on a large scale.

Question 3: Which region is dominating the sepsis diagnostics market?

Answer: Globally, North America is dominating the sepsis diagnostics market. The advancement healthcare industry is one of the major factors responsible for the growth of the reviewed market in the region. Additionally, the high mortality rate associated with sepsis patients is augmenting the demand for sepsis diagnostics in the US and Canada. Besides, the favorable healthcare reimbursement policies initiated by the governments are increasing the adoption of automated sepsis diagnostic analyzers. Hence, as stated above, all these factors play a major role in driving the sepsis diagnostics market on a growth path in the US and Canada.

Question 4: Which are the well-known companies in the sepsis diagnostics market?

Answer: EKF Diagnostics, Thermo Fisher Scientific Inc, Becton Dickinson and Company (CR Bard), Bruker Corporation, Response Biomedical Corporation, Luminex Corporation, Immunexpress Inc, Abbott Laboratories, Cytosorbents, Biomerieux SA, T2 Biosystems Inc, Danaher Corporation, and F Hoffmann-La Roche are well-known companies in the sepsis diagnostics market.

 

Related Report:

Global Surgical Site Infection Control Market

The global surgical site infection control market is calculated to advance at a CAGR of 5.95% during the forecasting period of 2021-2028, while garnering $6969.5 million in revenue by 2028.

Surgical site infection (SSI) refers to an infection that arises post-surgery on the part where the surgery was conducted. These infections can be deep incisional or organ-related.

The growing aging population and enactment of efficient infection prevention practices are key drivers motivating the development of the studied market globally. Besides, the increase in the number of surgical procedures, along with a significant rise in the prevalence of complications from healthcare-related infections, open new avenues for the market to reach its anticipated growth.

However, the lack of infection control programs, surging use of outpatient procedures, and increased use of disposable medical items are prominent factors hampering the global market’s overall growth.

 

About Us:

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

Media Contact
Company Name: Triton Market Research
Contact Person: Matt Dixson
Email: Send Email
Phone: +44 7441 911839
Address:196, wards wharf approach London E16 2EQ
Country: United Kingdom
Website: https://www.tritonmarketresearch.com/

Related Articles